Every healthcare company in our US universe is scored on the same transparent quality-growth model — one 0–100 score that blends business quality (margins and returns on capital), growth (revenue and earnings), and value (what you pay for them). The table below ranks them by that score, highest first, and re-scores every trading day.
Drug makers, medical devices, and diagnostics — durable demand and strong returns on capital, from profitable biotech to device compounders.
| # | Ticker | Company | Score |
|---|---|---|---|
| 1 | HRMYBiotechnology | Harmony Biosciences Holdings, Inc. | 88.5 |
| 2 | OSCRHealthcare Plans | Oscar Health, Inc. | 87.6 |
| 3 | NBIXDrug Manufacturers - Specialty & Generic | Neurocrine Biosciences, Inc. | 87.2 |
| 4 | ADMABiotechnology | ADMA Biologics, Inc. | 86.3 |
| 5 | INCYBiotechnology | Incyte Corporation | 84.1 |
| 6 | HALOBiotechnology | Halozyme Therapeutics, Inc. | 83.1 |
| 7 | ANIPDrug Manufacturers - Specialty & Generic | ANI Pharmaceuticals, Inc. | 82.7 |
| 8 | DXCMMedical Devices | DexCom, Inc. | 81.5 |
| 9 | PODDMedical Devices | Insulet Corporation | 81.3 |
| 10 | GMEDMedical Devices | Globus Medical, Inc. | 80.5 |
| 11 | LLYDrug Manufacturers - General | Eli Lilly and Company | 77.3 |
| 12 | ARGXBiotechnology | argenx SE | 77.2 |
| 13 | MEDPDiagnostics & Research | Medpace Holdings, Inc. | 76.6 |
| 14 | AVAHMedical Care Facilities | Aveanna Healthcare Holdings Inc. | 76.3 |
| 15 | INVABiotechnology | Innoviva, Inc. | 76.1 |
| 16 | RMDMedical Instruments & Supplies | ResMed Inc. | 75.9 |
| 17 | EXELBiotechnology | Exelixis, Inc. | 75.4 |
| 18 | ALNYBiotechnology | Alnylam Pharmaceuticals, Inc. | 75.2 |
| 19 | ISRGMedical Instruments & Supplies | Intuitive Surgical, Inc. | 75.1 |
| 20 | ADUSMedical Care Facilities | Addus HomeCare Corporation | 74.5 |
| 21 | LMATMedical Instruments & Supplies | LeMaitre Vascular, Inc. | 74.4 |
| 22 | MCKMedical Distribution | McKesson Corporation | 74.2 |
| 23 | UHSMedical Care Facilities | Universal Health Services, Inc. | 74.2 |
| 24 | AZNDrug Manufacturers - General | AstraZeneca PLC | 72.0 |
| 25 | CAIBiotechnology | Caris Life Sciences, Inc. | 72.0 |
| 26 | CONMedical Care Facilities | Concentra Group Holdings Parent, Inc. | 72.0 |
| 27 | HNGEHealth Information Services | Hinge Health, Inc. | 72.0 |
| 28 | CIHealthcare Plans | The Cigna Group | 71.9 |
| 29 | IDXXDiagnostics & Research | IDEXX Laboratories, Inc. | 71.8 |
| 30 | BSXMedical Devices | Boston Scientific Corporation | 71.4 |
| 31 | CDNADiagnostics & Research | CareDx, Inc. | 71.0 |
| 32 | DOCSHealth Information Services | Doximity, Inc. | 70.8 |
| 33 | KRYSBiotechnology | Krystal Biotech, Inc. | 70.7 |
| 34 | PAHCDrug Manufacturers - Specialty & Generic | Phibro Animal Health Corporation | 70.7 |
| 35 | VEEVHealth Information Services | Veeva Systems Inc. | 70.6 |
| 36 | OPCHMedical Care Facilities | Option Care Health, Inc. | 70.3 |
| 37 | PACSMedical Care Facilities | PACS Group, Inc. | 70.1 |
| 38 | DVAMedical Care Facilities | DaVita Inc. | 69.8 |
| 39 | GRDNMedical Care Facilities | Guardian Pharmacy Services, Inc. | 69.8 |
| 40 | ALHCHealthcare Plans | Alignment Healthcare, Inc. | 69.7 |
Every scored name in the sector, grouped by the industry it reports under.
Recent headlines across the sector's top-ranked names · updated daily. Links open the source.
Across the 205 Healthcare names with a reading, the median forward earnings estimate is roughly unchanged — +0.9% over 90 days, in line with the market (+0.5%). Opinion is close to evenly divided — 95 up, 55 down.
Estimates implied by price ÷ forward P/E, captured together each trading day since June 2026, and outside the Bull Rankings score. 205 of 295 members carry a reading; the rest have no forward P/E to imply one from, which is normal for loss-makers. How this is measured, across the market →
Every healthcare stock in our US universe is scored on the Bull Rankings quality-growth model — one 0–100 score blending business quality, growth, and valuation.
It is a single transparent 0–100 score combining profitability and returns on capital (quality), revenue and earnings growth (growth), and how much you pay for them (value). A higher score means a stronger business at a more reasonable price.
The universe is re-scored every trading day after the US market close, so the ranking reflects the latest fundamentals and prices.